Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

(2016) Stefano Ballestri et al.   ADVANCES IN THERAPY

Hypertriglyceridemia Associated With Abdominal Obesity: Figure.

(2015) André C. Carpentier   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Acute pancreatitis associated with severe hypertriglyceridaemia; A retrospective cohort study

(2015) Annika Charlesworth et al.   International Journal of Surgery

Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting

(2014) Qilin Gu et al.   HEPATOLOGY

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

(2014) Un Jung et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

(2013) P. Loria et al.   ATHEROSCLEROSIS

A Novel Mouse Model of Combined Hyperlipidemia Associated With Steatosis and Liver Injury by a Single-Dose Intragastric Administration of Schisandrin B/Cholesterol/Bile Salts Mixture

(2013) Si-Yuan Pan et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

(2012) James L. Trevaskis et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Postprandial metabolism of meal triglyceride in humans

(2012) Jennifer E. Lambert et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia

(2012) Ke-Wu Zeng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB

(2012) Rahul Checker et al.   FREE RADICAL BIOLOGY AND MEDICINE

Hyperlipidemia in patients with schizophrenia: a national population-based study

(2012) Jer-Hwa Hsu et al.   GENERAL HOSPITAL PSYCHIATRY

Periodontal Status and Hyperlipidemia: Statin Users Versus Non-Users

(2012) Aditi Sangwan et al.   JOURNAL OF PERIODONTOLOGY

Pathophysiology of hypertriglyceridemia

(2011) H.C. Hassing et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Hypertriglyceridemia secondary to obesity and diabetes

(2011) Savitha Subramanian et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Obesity, inflammation, and liver cancer

(2011) Beicheng Sun et al.   JOURNAL OF HEPATOLOGY

Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate

(2011) Si-Yuan Pan et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo

(2011) Yang Xu et al.   PLoS One

Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient

(2011) G. F. Watts et al.   POSTGRADUATE MEDICAL JOURNAL

Nonalcoholic fatty liver disease and mitochondrial dysfunction

(2008) Yongzhong Wei et al.   WORLD JOURNAL OF GASTROENTEROLOGY